Oncology
Our strong oncology portfolio provides cancer patients with a broad range of innovative therapies and practical solutions.
Our efforts to discover and develop innovative approaches for the treatment of cancer have produced breakthrough medicines such as:
-
Femara (letrozole) for early-stage or advanced breast cancer in postmenopausal women
-
Zometa (zoledronic acid) for prevention of skeletal-related events in patients with bone metastases from solid tumors
-
Exjade (deferasirox) for the removal of excess iron due to blood transfusions
-
Afinitor (everolimus) for advanced renal cell carcinoma (kidney cancer)
Visit the Novartis Oncology Websites:
Visit the Novartis Oncology US website
Visit the Novartis Oncology Global website
Glivec/Gleevec
Learn more about our groundbreaking cancer treatment.
Visit the Glivec website:
Magic Cancer Bullet
In this book, Dr. Vasella recounts the story of our revolutionary cancer drug Glivec/Gleevec.